ImmunoCelluar Therapeutics Ltd. (OTC: IMUC)
TNS members were alerted to OTC traded IMUC at $.95 on new drug trials. IMUC closed on 09/19/09 at $1.22, yielding a 29% ROI.
TooNiceStocks.com may or may not have been compensated for profiling this ticker. As always read full disclaimer here.


